Kreatech recently launched its monoclonal anti-cyanine 3 and anti-cyanine 5 antibodies. The company claims that the antibodies are suitable for detection and enhancement of signals from cyanine 3 and cyanine 5 labeled nucleic acids or proteins, and are applicable to microarray experiments, in situ hybridizations, immunohistochemistry, western blotting or flow cytometry.
According to the Dutch biotech, the anti-cyanine 5 antibody can be used to detect Cy5, Dyomics 647 or AlexaFluor 647, bound to proteins or nucleic acid probes. The anti-cyanine 3 antibody can be used to detect Cy3, or Dyomics 547, bound to proteins or nucleic acid probes. Anti-cyanine 3 and anti-cyanine 5 antibodies can be used in single- or dual-color assays.
SRU Biosystems last week launched its BIND System, with its accompanying BIND Reader and BIND Biosensor plates for drug discovery applications.
The life sciences company claims that the system enables label-free detection of biomolecular interactions using proteins, peptides or cells and can provide sensitive measurement of binding on the biosensor surface. SRU recommends the system for use in basic research, drug discovery, development, manufacturing, and QC.